Health Catalyst Overview
Health Catalyst Target Price
Analysts' 12-month price predictions for HCAT.
Share Price
$6.79
Average Target Price
$14.00
106.2% upside
106.2% upside1 analysts in the last 4 months
High: $14 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-01-26 | GuggenheimJack Wallace | $14 | 106.2% upside |  |
| 2022-05-11 | Piper SandlerJessica Tassan | $21 | 209.3% upside | |
| 2022-03-02 | Evercore ISIElizabeth Anderson CFA | $48 | 606.9% upside | |
| 2022-03-02 | RBC CapitalSean Dodge | $35 | 415.5% upside | |
| 2022-02-11 | Goldman SachsCindy Motz CFA | $48 | 606.9% upside | |
| 2021-05-27 | GuggenheimSandy Draper | $60 | 783.7% upside | |
| 2021-05-07 | Cantor FitzgeraldSteven Halper | $60 | 783.7% upside | |